Overview

Dyad Oxytocin Study (DOS)

Status:
Completed

Trial end date:
2017-10-01

Target enrollment:

Participant gender:

Summary

The purpose of the investigators proposed study is twofold: 1) To investigate the role of the affiliative neuropeptide oxytocin in unhealthy interactions in families of patients with schizophrenia and families of patients with autism spectrum disorder, and 2) to investigate whether manipulation of this oxytocinergic system positively influences these family interactions.

Phase:

Phase 1

Details

Lead Sponsor:

University of California, San Francisco

Treatments:

Oxytocin